SomnoMed racks highest sales of SomnoDent® devices to date - The Sleep and Respiratory Scholar
SomnoMed (ASX: SOM) continues to break its own records, delivering a 16% increase in sales of its SomnoDent® devices in the final quarter of the 2012 financial year, compared to the same period last year, with total revenues coming in at 37% higher at over A$4.5 million. The company provides diagno
Randy Clare